AGIOS PHARMACEUTICALS, INC. Unrecognized Tax Benefits
AGIOS PHARMACEUTICALS, INC. (AGIO) had Unrecognized Tax Benefits of $35.79 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-12
- 2025-12-31: Unrecognized Tax Benefits $35.79M.
- 2024-12-31: Unrecognized Tax Benefits $31.59M.
- 2023-12-31: Unrecognized Tax Benefits $28.58M.
- 2022-12-31: Unrecognized Tax Benefits $26.19M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $35.79M 10-K · filed 2026-02-12 |
| 2024-12-31 | $31.59M 10-K · filed 2026-02-12 |
| 2023-12-31 | $28.58M 10-K · filed 2026-02-12 |
| 2022-12-31 | $26.19M 10-K · filed 2025-02-13 |
| 2021-12-31 | $24.22M 10-K · filed 2024-02-15 |
| 2020-12-31 | $21.13M 10-K · filed 2023-02-23 |
| 2019-12-31 | $17.46M 10-K · filed 2022-02-24 |
| 2018-12-31 | $14.29M 10-K · filed 2021-02-25 |
| 2017-12-31 | $11.26M 10-K · filed 2020-02-19 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-14 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-14 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-26 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 |
| 2013-06-30 | $0.00 10-Q · filed 2013-09-05 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |